Department of Radiotherapy and Oncology, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Institute of Radiotherapy and Oncology, Soochow University, Suzhou, China.
Front Public Health. 2022 Mar 28;10:862598. doi: 10.3389/fpubh.2022.862598. eCollection 2022.
It is difficult to study the intestinal damage induced by space radiation to astronauts directly, and few prediction models exist. However, we can simulate it in patients with pelvic tumor radiotherapy (RT). Radiation-induced intestinal injury (RIII) is common in cancer patients who receieved pelvic and abdominal RT. We dynamically analyzed gut microbiota and metabolites alterations in 17 cervical and endometrial cancer patients after pelvic RT. In patients who later developed grade 2 RIII, dysbiosis of gut microbiota and metabolites were observed. Univariate analysis showed that and ptilosteroid A were related to the occurrence of grade 2 RIII. Notably, a strong positive correlation between gut bacteria relative abundance and gut metabolite ptilosteroid A expression was found. Furthermore, combinations of and ptilosteroid A could provide good diagnostic markers for grade 2 RIII. In conclusion, gut bacteria and its related metabolite ptilosteroid A may collaboratively predict RIII, and could be diagnostic biomarkers for RIII and space radiation injury.
很难直接研究太空辐射对宇航员造成的肠道损伤,并且很少有预测模型。然而,我们可以在接受盆腔肿瘤放射治疗(RT)的患者中模拟它。辐射诱导的肠道损伤(RIII)在接受盆腔和腹部 RT 的癌症患者中很常见。我们对 17 例宫颈癌和子宫内膜癌患者盆腔 RT 后肠道微生物群和代谢物的变化进行了动态分析。在后来发生 2 级 RIII 的患者中,观察到肠道微生物群和代谢物的失调。单变量分析表明, 和 ptilosteroid A 与 2 级 RIII 的发生有关。值得注意的是,发现肠道细菌 的相对丰度与肠道代谢物 ptilosteroid A 的表达之间存在很强的正相关。此外, 和 ptilosteroid A 的组合可以为 2 级 RIII 提供良好的诊断标志物。总之,肠道细菌 及其相关代谢物 ptilosteroid A 可能协同预测 RIII,并且可以作为 RIII 和太空辐射损伤的诊断生物标志物。